Investors Overview

Press Release

View printer-friendly version

Becton, Dickinson and Company Announces Results of Early Tenders and Consents in Exchange Offers

FRANKLIN LAKES, N.J., April 9, 2015 /PRNewswire/ -- Becton, Dickinson and Company (NYSE: BDX) ("BD") announced today that, as of 5:00 p.m., New York City time, on April 8, 2015 (the "Early Consent Date"), the aggregate principal amounts listed in the table below of each series of notes listed in the table below (collectively, the "Existing Notes") previously issued by CareFusion Corporation, a wholly owned subsidiary of BD, had been validly tendered and not validly withdrawn in connection with BD's previously announced offers to exchange all validly tendered and accepted notes of each such series of Existing Notes for new notes to be issued by BD (collectively, the "New Notes"), and the related solicitation of consents to amend the indentures governing the Existing Notes. A Registration Statement on Form S-4 (File No. 333-203013) (the "Registration Statement") relating to the issuance of the New Notes was filed with the Securities and Exchange Commission ("SEC") on March 26, 2015, as amended by Amendment No. 1 to Form S-4, filed with the SEC on April 9, 2015, but has not yet been declared effective.  

 

Series of Existing Notes
to be Exchanged

Tenders and Consents
Received as of the Early Consent Date

Percentage of Total
Outstanding Principal
Amount of such Series of Existing Notes

1.450% Senior Notes due May 15, 2017

$291,978,000

97.33%

6.375% Senior Notes due August 1, 2019

$661,140,000

94.45%

3.300% Senior Notes due March 1, 2023

$293,850,000

97.95%

3.875% Senior Notes due May 15, 2024

$396,380,000

99.10%

4.875% Senior Notes due May 15, 2044

$299,877,000

99.96%

 

The exchange offers and consent solicitations (together, the "Exchange Offers") are being made pursuant to the terms and conditions set forth in BD's preliminary prospectus, dated as of March 26, 2015 (the "Prospectus"), which forms a part of the Registration Statement, and the related Letter of Transmittal and Consent (the "Letter of Transmittal") that contain a more complete description of the terms and conditions of the Exchange Offers.  Subject to the Registration Statement being declared effective, the Exchange Offers will expire at 11:59 p.m. on April 22, 2015.

The dealer managers for the Exchange Offers are:

Goldman, Sachs & Co.

200 West Street

New York, New York 10282

Attention: Liability Management Group

Toll-Free: (800) 828-3182

Collect: (212) 357-0215

J.P. Morgan Securities LLC

383 Madison Avenue

New York. New York 10179

Attention: Liability Management Group

Collect: (212) 834-4811

Toll-Free: (866) 834-4666

The exchange agent and information agent for the Exchange Offers is:

D.F. King & Co., Inc.

48 Wall Street, 22nd Floor

New York, New York 10005

Attn: Krystal Scrudato

Bank and Brokers Call Collect: (212) 269-5550

All Others, Please Call Toll-Free: (866) 416-0576

Email: cfn@dfking.com

 

This press release shall not constitute an offer to sell, or a solicitation of an offer to buy, any of the securities described herein and is also not a solicitation of the related consents. The Exchange Offers may be made only pursuant to the terms and conditions of the Prospectus, the Letter of Transmittal and the other related materials.  A Registration Statement relating to the New Notes has been filed with the SEC but has not yet become effective.  The New Notes may not be sold, nor may offers to buy be accepted, prior to the time the Registration Statement is declared effective by the SEC. 

Contact:
Kristen Cardillo
Media
(858) 617-2317
Email: Kristen.Cardillo@carefusion.com

Monique N. Dolecki 
Investor Relations
(201) 847-5378
Email: monique_dolecki@bd.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/becton-dickinson-and-company-announces-results-of-early-tenders-and-consents-in-exchange-offers-300063877.html

SOURCE BD (Becton, Dickinson and Company)

Investor Highlights

Placeholder

Meet Jonathan

Moments after crossing the finish line of a half marathon, Jonathan went into cardiac arrest due to a congenital defect in his artery.
Placeholder

Drone Delivery Capabilities

See how BD and WeRobotics worked to advance drones for healthcare in the Peruvian Amazon
Placeholder

AMR Leadership

BD solutions to combat antimicrobial resistance

© 2019 BD. All rights reserved. Unless otherwise noted, BD, the BD Logo and all other trademarks are property of Becton, Dickinson and Company.